Eton Pharmaceuticals (ETON) Gains from Investment Securities (2019 - 2025)
Eton Pharmaceuticals (ETON) has disclosed Gains from Investment Securities for 7 consecutive years, with -$1167.0 as the latest value for Q4 2025.
- Quarterly Gains from Investment Securities fell 100.54% to -$1167.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $215833.0 through Dec 2025, down 0.54% year-over-year, with the annual reading at $5.9 million for FY2025, 0.12% changed from the prior year.
- Gains from Investment Securities hit -$1167.0 in Q4 2025 for Eton Pharmaceuticals, down from $6.0 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $6.3 million in Q2 2024 to a low of -$1167.0 in Q4 2025.
- Historically, Gains from Investment Securities has averaged $2.6 million across 5 years, with a median of $1.3 million in 2022.
- Biggest five-year swings in Gains from Investment Securities: surged 13766.67% in 2021 and later plummeted 100.54% in 2025.
- Year by year, Gains from Investment Securities stood at $3.6 million in 2021, then crashed by 64.46% to $1.3 million in 2022, then tumbled by 95.99% to $50867.0 in 2023, then soared by 326.6% to $217000.0 in 2024, then tumbled by 100.54% to -$1167.0 in 2025.
- Business Quant data shows Gains from Investment Securities for ETON at -$1167.0 in Q4 2025, $6.0 million in Q3 2025, and $6.0 million in Q2 2025.